 Centers for Medicare and Medicaid Services CMS issued its fiscal 2022 proposed physician fee schedule, which included two combined Category I cataract plus stent procedure codes. The physicians will use the codes to seek reimbursement utilizing Glaukos Corporations NYSE: GKOS trabecular micro-bypass technologies iStent, iStent inject, iStent inject W when used as approved in combination with cataract surgery. 